» Authors » Daniel Barthelmes

Daniel Barthelmes

Explore the profile of Daniel Barthelmes including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 183
Citations 1968
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Perschak P, Said S, Metzler S, Zweifel S, Barthelmes D, Hermann D, et al.
Klin Monbl Augenheilkd . 2025 Feb; PMID: 40015311
Background: If used properly, contact lenses (CLs) provide a safe and effective alternative to eyeglasses for refractive error correction. However, often due to patient noncompliance, CL-related complications may occur, such...
2.
Blaser F, Meneau I, Schneider J, Wiedler J, Hinrikson H, Barthelmes D, et al.
Klin Monbl Augenheilkd . 2025 Feb; PMID: 40015309
Purpose: For specific samples, there are different methods and requirements for testing sterility. Blood and blood products are analyzed using automated blood culture methods, while pharmacopeial sterility is assessed using...
3.
Mhmud H, Tigchelaar-Besling O, Vermeulen J, Verbraak F, Barthelmes D, Gillies M, et al.
Ned Tijdschr Geneeskd . 2025 Feb; 169. PMID: 40013669
Objective: To study the long-term outcomes of anti-VEGF treatment for neovascular age-related macular degeneration (nAMD) in the Netherlands, where off-label bevacizumab is used as the first choice, compared to countries...
4.
Ponsioen T, Hashimoto Y, Invernizzi A, Gabrielle P, Lavid F, Mehta H, et al.
Clin Exp Ophthalmol . 2024 Dec; PMID: 39731402
Background: We aimed to describe a 2-year outcome of eyes managed by practitioners benchmarked using a funnel plot by their frequency of treatment using vascular endothelial growth factor (VEGF) inhibitors...
5.
Invernizzi A, Airaldi M, Cozzi M, Nguyen V, Hashimoto Y, Barthelmes D, et al.
Clin Exp Ophthalmol . 2024 Dec; PMID: 39638986
Background: To assess clinical outcomes of cataract surgery in eyes treated with intravitreal injections for cystoid macular oedema (CMO) secondary to retinal vein occlusions (RVOs). Methods: Eyes receiving intravitreal injections...
6.
Hashimoto Y, Hunt A, Wells J, Banerjee G, Ferrier R, Barry R, et al.
Br J Ophthalmol . 2024 Nov; PMID: 39542710
Background: To compare individual ophthalmologists grouped as outliers or non-outliers based on the mean 12-month visual acuity (VA) outcomes for their patients with neovascular age-related macular degeneration (nAMD). Methods: This...
7.
Mares V, Reiter G, Gumpinger M, Leigang O, Bogunovic H, Barthelmes D, et al.
Acta Ophthalmol . 2024 Nov; PMID: 39540601
Purpose: To quantify ellipsoid zone (EZ) loss during anti-VEGF therapy for neovascular age-related macular degeneration (nAMD) and correlate these findings with nAMD disease activity using artificial intelligence-based algorithms. Methods: Spectral...
8.
Simunovic M, Moore A, Grigg J, Sergouniotis P, Mahroo O, Vincent A, et al.
Retina . 2024 Oct; 45(2):286-295. PMID: 39418576
Purpose: To design and build a new disease registry to track the natural history and outcomes of approved gene therapy in patients with inherited retinal diseases. Methods: A core committee...
9.
Puzo M, Calvo-Perez P, Bartol-Puyal F, Sanchez-Monroy J, Martin-Pinardel R, Parrado-Carrillo A, et al.
Eye (Lond) . 2024 Sep; 38(18):3450-3458. PMID: 39306616
Objectives: To compare visual outcomes for low vision eyes (LVE) (<35 letters LogMAR or <20/200 Snellen) versus non-low vision eyes (NLVE) (>35 letters LogMAR or >20/200 Snellen) at the time...
10.
Bajka A, Said S, Quiblier C, Schulthess B, Reinhold I, Barthelmes D, et al.
Microorganisms . 2024 Aug; 12(8). PMID: 39203477
Fungal keratitis is a rare yet severe infection of the cornea. Fungal species distribution depends on the climate and socioeconomic status and can show regional variation. This retrospective single-center study...